• Explore /
  • Poster
  • / Recurrence-free survival as a surrogate for overall survival in esophageal squamous cell carcinoma: Nationwide real-world data from Japan.

Recurrence-free survival as a surrogate for overall survival in esophageal squamous cell carcinoma: Nationwide real-world data from Japan.

Abstract Poster

Authors

null

Jun Okui

Department of Surgery, Keio University School of Medicine, Tokyo, Japan

Jun Okui , Kengo Nagashima , Satoru Matsuda , Yasunori Sato , Akihiko Okamura , Hirofumi Kawakubo , Manabu Muto , Yoshihiro Kakeji , Koji Kono , Hiroya Takeuchi , Masayuki Watanabe , Yuichiro Doki , Takeo Bamba , Takashi Fukuda , Hitoshi Fujiwara , Shinsuke Sato , Kazuhiro Noma , Hiroshi Miyata , Takeo Fujita , Yuko Kitagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 269)

DOI

10.1200/JCO.2024.42.3_suppl.269

Abstract #

269

Poster Bd #

C7

Abstract Disclosures

Similar Posters

First Author: Ken Kato

First Author: Shota Igaue

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

First Author: Yuri Yoshinami

First Author: Takahiro Tsushima